Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Affimed Stock Is Heating Up Today

TheMotleyFool

0 0

Shares of German cancer immunotherapy company Affimed (NASDAQ: AFMD) were up by a healthy 7.1% as of 11:59 a.m. ET Monday. The biotech's stock was flying higher in response to a positive clinical update for its lead blood cancer therapy, AFM13.

AFM13 is a tetravalent bispecific antibody that links natural killer cells to tumor cells. Affimed provided its latest progress report via an oral presentation at the American Association for Cancer Research's annual meeting over the weekend.

Image source: Getty Images.

Source Fool.com

Like: 0

AFMD

Share